162 related articles for article (PubMed ID: 25926588)
21. Antineutrophil Cytoplasmic Antibody-associated Vasculitis Superimposed on Infection-related Glomerulonephritis Secondary to Pulmonary Mycobacterium avium Complex Infection.
Asano S; Mizuno S; Okachi S; Aso H; Wakahara K; Hashimoto N; Ito S; Kozaki Y; Katsuno T; Maruyama S; Hasegawa Y
Intern Med; 2016; 55(17):2439-45. PubMed ID: 27580547
[TBL] [Abstract][Full Text] [Related]
22. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
[TBL] [Abstract][Full Text] [Related]
23. Cure Not Possible, by Definition.
Wassilew N; Lange C
Am J Respir Crit Care Med; 2015 Nov; 192(10):1255-6. PubMed ID: 26568243
[No Abstract] [Full Text] [Related]
24. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
Kuwabara K; Tsuchiya T
Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):587-92. PubMed ID: 17763685
[TBL] [Abstract][Full Text] [Related]
25. [A clinical study on cases with pulmonary M. avium complex (MAC) disease followed up for more than 10 years].
Harada S; Harada Y; Ochiai S; Emori M; Kajiki A; Kitahara Y; Takamoto M; Ishibashi T
Kekkaku; 2003 Aug; 78(8):517-23. PubMed ID: 14509223
[TBL] [Abstract][Full Text] [Related]
26. Cavitary pulmonary disease in a patient treated with natalizumab.
de Masson A; Maillart E; Veziris N; Meyssonnier V; Papeix C; Caumes E
Presse Med; 2014 Sep; 43(9):1009-12. PubMed ID: 24742610
[No Abstract] [Full Text] [Related]
27. [Pulmonary changes in ulcerative colitis].
Hold G; Bolognini G; Russi E
Schweiz Med Wochenschr; 1992 Sep; 122(37):1363-8. PubMed ID: 1411394
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
[TBL] [Abstract][Full Text] [Related]
29. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.
Moon SM; Park HY; Kim SY; Jhun BW; Lee H; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2016 Nov; 60(11):6758-6765. PubMed ID: 27572413
[TBL] [Abstract][Full Text] [Related]
31. Reply: Cure Not Possible, by Definition.
Griffith DE; Adjemian J; Brown-Elliott BA; Prevots DR; Philley JV; Olivier KN; Wallace RJ
Am J Respir Crit Care Med; 2015 Nov; 192(10):1256-7. PubMed ID: 26568244
[No Abstract] [Full Text] [Related]
32. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Lee G; Lee KS; Moon JW; Koh WJ; Jeong BH; Jeong YJ; Kim HJ; Woo S
Ann Am Thorac Soc; 2013 Aug; 10(4):299-306. PubMed ID: 23952847
[TBL] [Abstract][Full Text] [Related]
33. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Lam PK; Griffith DE; Aksamit TR; Ruoss SJ; Garay SM; Daley CL; Catanzaro A
Am J Respir Crit Care Med; 2006 Jun; 173(11):1283-9. PubMed ID: 16514112
[TBL] [Abstract][Full Text] [Related]
34. Acute pneumonia and empyema caused by Mycobacterium intracellulare.
Park SU; Koh WJ; Kwon OJ; Park HY; Jun HJ; Joo EJ; Lee NY; Kim TS; Lee KS; Park YK
Intern Med; 2006; 45(17):1007-10. PubMed ID: 17016001
[TBL] [Abstract][Full Text] [Related]
35. Mycobacterium avium complex lung disease therapy.
Griffith DE; Winthrop KL
Am J Respir Crit Care Med; 2012 Sep; 186(6):477-9. PubMed ID: 22984024
[No Abstract] [Full Text] [Related]
36. Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease.
Min J; Park J; Lee YJ; Kim SJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1239-45. PubMed ID: 26459540
[TBL] [Abstract][Full Text] [Related]
37. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
Jeong BH; Jeon K; Park HY; Moon SM; Kim SY; Lee SY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):6076-83. PubMed ID: 27480854
[TBL] [Abstract][Full Text] [Related]
38. [Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens].
Shirai M; Hayakawa H; Nakano Y; Kuroishi S; Nakano Y; Todate A; Suda T; Chida K
Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):875-9. PubMed ID: 15566000
[TBL] [Abstract][Full Text] [Related]
39. Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung).
Khoor A; Leslie KO; Tazelaar HD; Helmers RA; Colby TV
Am J Clin Pathol; 2001 May; 115(5):755-62. PubMed ID: 11345841
[TBL] [Abstract][Full Text] [Related]
40. Consolidations in nodular bronchiectatic Mycobacterium avium complex lung disease: Mycobacterium avium complex or other infection?
Im SA; Park HJ; Park SH; Chun HJ; Jung WS; Kim SH
Yonsei Med J; 2010 Jul; 51(4):546-51. PubMed ID: 20499420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
